Webcasts
Webinar Date/Time: Tue, Jun 9, 2026 11:00 AM EDT
Discover the critical steps that keep European Union and United Kingdom clinical supplies moving by understanding what a QP truly needs to prevent delays. Learn how smarter documentation, clearer communication, and proactive planning can significantly reduce risk and accelerate your trial timelines.
Register Free: https://www.pharmtech.com/pt_w/qp
Event Overview:
Delivering clinical trial supplies into the European Union and United Kingdom requires rigorous oversight from a Qualified Person (QP) to ensure every batch meets regulatory, GMP, and trial-specific requirements. Yet, many sponsors face preventable delays, often due to incomplete documentation, limited supply chain visibility, or late communication of changes. In this session, Catalent experts will break down the core responsibilities of the QP, explain how European Union and United Kingdom expectations differ, and share practical steps sponsors can take to streamline the certification process. Attendees will learn how to prepare audit-ready documentation, avoid common pitfalls that extend release timelines, and build efficient collaborations with QPs to keep studies moving without interruption.
Key Learning Objectives
Who Should Attend
Speaker:
Johannes Hirt
Senior Batch Processing Manager, Qualified Person
Catalent
Johannes Hirt, Pharmacist, is Senior Manager and Qualified Person at Catalent’s Schorndorf facility in Germany. He leads a team of Batch Processing Managers and QPs, ensuring compliance with European Union GMP and working closely with the Bathgate, Scotland, facility for United Kingdom GMP for clinical medicinal products. Hirt offers practical quality oversight, audit guidance, and supply chain visibility, supporting sponsors in regulatory requirements and efficient QP certification.
Register Free: https://www.pharmtech.com/pt_w/qp